Home Companies Biochimpharm

Biochimpharm

Sector/Subsector:
Chemicals & Pharmaceutics / Pharmaceutical production
Other Industries / Veterinary medicine & Food/feed additives

Contact information

Description

BioChimPharm (BCP) is a Georgian-based, biopharmaceutical Company engaged in R&D, production and marketing of sustainable alternative to antibiotics. To develop innovative products, we use bacteriophages (phages), which are the natural enemies of bacteria. The Company possesses unique technological knowhow and over 80 years of accumulated experience in R&D and the production of antibiotic alternatives. BCP is an ISO 9001-2015 certified, multi-award-winning Company with more than 50 people, 15 registered products and two international patents. The Company exports its products to regional and international markets and is a regulatory authorized pharmaceutical manufacturer. The company’s production site and R&D laboratories are located in Tbilisi, Georgia in the historic bacteriophage production facility built in 1934.

BioChimPharm's product portfolio includes solutions used for treatment and prevention of diseases caused by harmful (pathogenic) bacteria. Company mainly operates in two, Human and Animal Health, industries producing therapeutic OTCs (over the counter drugs) and dietary supplements. BCP’s mission is to eradicate the irrational use of antibiotics and to overcome antibiotic resistance challenge globally. With accumulated experience of over 80 years and combined effort of several generations we are making revolutionary technology globally available.

Countries

Georgia

Year of foundation

1999

Certificates

ISO 9001:2015, License of Permission for Pharmaceutical Production

Awards

1. Winner of ENPARD Sustainability Competition organized by the EUROPEAN UNION and Food & Agriculture Organization - FAO (2020) 2. Winner of Innovation Awards Organized by The Wolrd Bank and Georgia’s Innovation & Technology Agency - GITA (2019) 3. Received SEAL OF EXCELLENCE from the European Commission for developing a breakthrough technology targeting antibiotic resistant infections (2019) 4. Innovative Business of the Year (2016) 5. Leader of the Biopharmaceutical Industry (2015)

Products

website.video_/_photo_gallery

Product preparation
Logistics
Trade Agreements
Obtain Financing
International Exhibitions

Statistics

Exporters Guide

Online Training

Online Chat
×